Scales Corp. Ltd. · NZX:SCL

Scales — H1 2022 Earnings Presentation

29 slides from Scales's earnings presentation, Aug 24, 2022

  1. Slide 1: Scales Corporation Half Year Results 2022

    SCALES CORPORATION LIMITED Bringing Nutrition to the World Half Year Results For the Six Months Ended 30 June 2022 24 August 2022 Scales Corporation Limited – 2022 Half Year Results 1 global nutrition

  2. Slide 2: Agenda

    1. 1H22 Overview 2. Global Proteins 3. Sustainability 4. Group Results 5. Divisional Performance 6. FY22 Outlook Appendices: I. NZ IFRS Reconciliation II. Disclaimer Scales Corporation Limited – 2022 Half Year Results 2 global nutrition

  3. Slide 3: 1. 1H22 Overview

    Ss ‘= > ee vo. > oy) AN

  4. Slide 4: Sustained growth in Food Ingredients, renamed Global Proteins

    Sustained growth in our Food Ingredients division has reaffirmed our belief in its global potential, particularly with regards to proteins. The success of our strategy, combined with the opportunities that are presenting themselves, has led to a renaming of the division to Global Proteins. Our strat

  5. Slide 5: 2. Global Proteins

    2. Global Proteins

  6. Slide 6: We are actively progressing our strategy objectives

    We are actively progressing our strategy objectives Petfood Ingredients Sold (MT 000s) • We firmly believe in the potential of the food ingredients opportunity. Given both the recent results of the division, and its global potential, we have changed the name of the division to better reflect its foc

  7. Slide 7: Global meat consumption and pet food consumption value

    • There is a correlation in the growth in petfood and human consumption protein demand Global Human Meat Consumption (MT) vs due to their related drivers: Global Petfood Consumption ($) ◦ Estimated global population of 8.6 billion by 2030, with most of the growth from developing / 700 $200 emerging

  8. Slide 8: Strong relationship between petfood and edible protein supply chains

    There is a strong relationship between petfood and edible protein supply chains • Scales’ strength in global proteins lies in its supplier and customer relationships coupled with its logistics network, and a reputation for quality products. Scales will look to leverage this expertise for complementa

  9. Slide 9: Our value proposition is our wide range of quality ingredients

    Our value proposition is our wide range of quality ingredients and end-to-end supply chain excellence • ‘One stop shop’ for customers and suppliers We source and • Global supply relationships supply premium Current and growing protein ingredients mismatch between protein supply and demand in • Speci

  10. Slide 10: Critical factors in becoming a global strategic partner

    The critical factors in becoming a global strategic partner to our customers and suppliers are: Sourcing globally improves Simplify the procurement supply continuity for our process for our customers customers, and accessing as many are wanting to new markets accelerates our consolidate supplier vol

  11. Slide 11: Secure global supply, expand species, access new markets

    Objective • We will enter into partnerships, joint ventures and alliances to further develop our supply network, either working alongside existing operations Secure global supply and that are complementary to our own or with protein suppliers to achieve access to additional protein sources access ne

  12. Slide 12: 3. Sustainability

    Mi ad SW ae ag, aa pas nicabte, 3:-Sustainabilit

  13. Slide 13: Continuous improvement

    Continuous improvement 2022 is about re-focusing on the key material issues • We are currently undertaking scenario analysis to better understand our future physical and transitional risks and opportunities • The aim is to then re-visit our material issues, and use this information to get clarity on

  14. Slide 14: 4. Group Results

    4. Group Results

  15. Slide 15: Diversification strategy delivering resilient and solid results

    Diversification strategy and strong teamwork delivering resilient and solid results • Reported NPAT Attributable to Shareholders of $26.1m (down 8.0% on 1H21) • Underlying NPAT Attributable to Shareholders of $25.6m (down 11.7% on 1H21) • Underlying NPAT of $34.7m (up 4.0% on 1H21) • Underlying EBIT

  16. Slide 16: Solid results underpinned by sustained growth in Global Proteins

    Solid results underpinned by sustained growth in Global Proteins • Global Proteins – an exceptionally strong 1H22, attributed to increased volumes sold together with changes in product mix and margins • Horticulture – strong in-market prices to date more than offset by reduced volumes and increased

  17. Slide 17: Strong financial position

    Balance Sheet Strong financial position $m Jun-22 Jun-21 Current assets excluding cash Trade & other receivables 101.6 77.0 • Net Cash of $16.8m at 30 June 2022 vs $38.0m at 30 June 2021 Inventories 38.7 32.7 Agricultural produce 85.4 74.4 • Agricultural produce represents unsold fruit at 30 June: O

  18. Slide 18: 5. Divisional Performance

    5. Divisional Performance

  19. Slide 19: Significant growth, reflecting ongoing global demand for petfood

    Significant growth, reflecting ongoing global demand for petfood • Excellent half year result: ◦ Underlying EBITDA of $30.4m (1H21: $16.1m), an increase of 88.6% ◦ 13% increase in volumes sold ◦ We expect that earnings for the 2H22 will be similar to 2H21 ◦ The development of new organic growth oppo

  20. Slide 20: Significant headwinds encountered

    Significant headwinds encountered • Underlying EBITDA $24.0m (1H21: $38.0m): ◦ Higher in-market pricing was offset by lower export volumes and increased labour and shipping costs • Mr Apple own-grown volumes lower than both forecast and 2021 volumes • Packhouse automation project progressing well Ho

  21. Slide 21: Volumes affected by weather and operational effects

    Volumes affected by weather and operational effects Mr Apple Own Export Volumes (TCE 000s) • The National crop volumes for 2022 are forecast to be around 6% less than 2021 ◦ Hawke’s Bay and other growing regions, impacted by adverse weather events during key growing period ◦ Industry affected by RSE

  22. Slide 22: Market diversification partially offset effects of difficult season

    Market diversification partially offset effects of difficult season • Inflation and the overall cost of living has curbed consumer spending globally ◦ Expected positive demand for the upcoming China Mid-Autumn Festival, although lockdowns impacted earlier sales volumes ◦ Steady demand in other Asian

  23. Slide 23: Strategic value continuing to prove important

    Strategic value continuing to prove important • Underlying EBITDA of $3.6m (1H21: $2.7m), an increase of 31.9% • Ongoing pressure on the global supply chain: ◦ Restricted shipping capacity, labour shortages and increased costs • Skill and expertise of team providing vital services and sourcing solut

  24. Slide 24: 6. Outlook

    6. Outlook

  25. Slide 25: Scales has updated its FY22 guidance

    Scales has updated its FY22 guidance • Directors advise that Underlying Net Profit Attributable to Shareholders is now expected to be at the upper-end of the previously advised range of $23.5m to $28.5m ◦ Due to the change in earnings mix, the implied Underlying Net Profit range has increased to $35

  26. Slide 26: Appendices

    —_ * Appendices ~ © *

  27. Slide 27: Reconciliation of Divisional Underlying Profitability to Reported Profitability

    Reconciliation of Divisional Underlying Profitability to Reported Profitability Group Global Proteins Horticulture Logistics Corporate & Eliminations $m 1H22 1H21 1H22 1H21 1H22 1H21 1H22 1H21 1H22 1H21 Underlying / Reported Revenue 309.3 253.8 151.7 99.8 117.3 127.4 67.9 43.6 (27.6) (17.0) EBITDA R

  28. Slide 28: Reconciliation of Divisional Underlying Profitability: NPAT

    Reconciliation of Divisional Underlying Profitability to Reported Profitability Group Global Proteins Horticulture Logistics Corporate & Eliminations $m 1H22 1H21 1H22 1H21 1H22 1H21 1H22 1H21 1H22 1H21 NPAT Reconciliation Underlying NPAT (excluding NZ IFRS 16) 34.8 33.6 24.3 13.3 10.1 20.3 2.2 1.6

  29. Slide 29: Disclaimer

    The information in this presentation has been prepared by Scales Corporation Limited with due care and attention. However, neither Scales Corporation Limited nor any of its directors, employees, shareholders nor any other person shall have any liability whatsoever to any person for any loss (includi

Scales — H1 2022 Earnings Presentation on 6ix